Sheffield University leads the way with diagnosis of rare blood disease

Have your say

Scentists from the University of Sheffield and Sheffield Teaching Hospitals NHS Trust have joined forces with renowned researchers from across the globe to launch a pioneering facility that aims to improve the diagnosis of a rare life threatening blood disease.

The National Academy of Clinical Flow Cytometry, which will be based at the University, will help to train scientists in the detection and monitoring of Paroxysmal Nocturnal Haemoglobinuria (PNH) to ensure the disease is diagnosed as early as possible.

PHN is a rare, life threatening, genetic condition that affects around two people in every million.

The condition can occur at any age and is characterised by the destruction of red blood cells by part of the body’s immune system that leads to a high risk of thrombosis.